Professor Dimitra Hadjipavlou-Litina received her undergraduate training in Pharmacy at Aristotle University of Thessaloniki, Greece (1975-1979) and her PhD in Pharmacy at the same University. She conducted postdoctoral studies at California (supervisor Professor Corwin Hansch). Currently she is a full professor and a head at the School of Pharmacy.

Her research interests involve synthesis and biological studies and the use of Computational Chemistry in Drug Design and resulted in the publication of over 220 peer-reviewed articles over 5000 citations and h factor = 38. Currently is the Editor of this journal (Current Enzyme Inbibition, CEI), published by Bentham Science Publishers.

Ahmed M Alafeefy got his PhD, Pharmaceutical Chemistry, in 2005 from Egypt and left to Saudi Arabia. His current research interest covers the development of potential drugs to combat cancer and viral diseases. He has been consistently working to locate biochemical rationale which enables the preparation of antitumor drugs focusing on qualitative differences between normal and cancerous cells. The complimentary development of semisynthetic biologically active small molecules as antiviral, anticancer agents is his future aim. Currently, he is an Assoc. Prof. of Pharmaceutical Chemistry Kulliyyah of Science, IIUM, Malaysia. He has published more than 40 papers in reputed journals.

Dr. Marc A. Ilies was born and educated in Romania, receiving his PhD in 2001 with Professor Alexandru T. Balaban, from C. D. Nenitzescu’s Department of Organic Chemistry of Polytechnic University of Bucharest. After post-doctoral studies Texas A&M University and University of Pennsylvania he joined the Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, where he is currently Associate Professor and an affiliated member of Moulder Center for Drug Discovery Research. His research interests fit within the broadly-defined medicinal chemistry/chemical biology of membrane interfaces, being focused on the development of chemical solutions for the efficient and selective delivery of drugs and nucleic acids for therapeutic purposes.

Dr Alane Beatriz Vermelho is Biologist, MSc and Dsc in Sciences (Microbiology) at the Federal University of Rio de Janeiro, Brazil, where she is a professor of the Department of General Microbiology and coordinates the Laboratory of Biotechnology Network BIONOVAR - Biocatalysis, Bioproducts and Bioenergy Unit. She Develops research with enzymes and other microbial bioproducts aimed at the Industrial Sector. She is currently Director of the Microbiology Institute Paulo de Góes, UFRJ. She is co-founder of the biotechnological spin off base HANA BIOCOSMETIC

Dr. Simone Carradori obtained his Ph.D. in Pharmaceutical Sciences from Sapienza University of Rome (Italy). Currently, he is assistant professor of Medicinal Chemistry at the Department of Pharmacy of “G. D’Annunzio” University of Chieti-Pescara (Italy). The scientific activity is mainly focused on the characterization and synthesis of novel synthetic and natural derivatives with potential biological activity and is documented from about 94 papers in international peer-reviewed journals and one patent.

Fabrizio Carta received his degree in 2002 in Pharmaceutical Chemistry and Technology from the University of Sassari (IT). On 2008 he received his Ph.D. in Chemistry at the School of Chemistry of the Bristol University (UK), was appointed as postdoctoral fellow at MIT (USA) and finally joined Prof. Scozzafava’s and Supuran’s groups at the University of Florence (IT). Among others he is Editorial Board Member di Journal of Enzyme Inhibition and Medicinal Chemistry (JEIMC) and Journal of the Turkish Chemical Society, Section A: Chemistry (JOTCSA). Co-author of 100 publications on peer-reviewed international journals, 3 book chapters. 4 patents.

Zeid A. ALOthman, Professor of Chemistry, at Chemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia. He obtained his Ph.D. in chemistry at Oklahoma State University in 2006.

He is working on a variety of topics ranging from the high surface area materials, Water treatment and production, Ion exchanger, separation and Environmental studies.

He is the group leader of Advanced Materials and Chromatography Group and the supervisor of the Advanced Materials Research Chair.

He supervised seven PhD students and more than 12 master students.

He is an author and co-author of more than 350 scientific publications, three books and six patents.

Dr. Akdemir obtained his PhD and MSc from the Department of Pharmaceutical Sciences (VU University Amsterdam, The Netherlands). His research interests are mainly molecular modelling and molecular pharmacology studies of various drug targets (including carbonic anhydrases and nicotinic acetylcholine receptors). He is currently associate professor of pharmacology and vice-dean at the Faculty of Pharmacy (Bezmialem Vakif University, Istanbul, Turkey).

Clemente Capasso is researcher at the National Research Council. His research interest from 1992 to date has been the study of the structure/function relationship of both native and recombinant proteins from terrestrial, marine organisms and pathogenic microorganisms This allowed him to acquire extensive knowledge of most protein purification procedures as well as kinetic, chemical–physical and structural characterization of enzymes. He has written 13 book chapters and published over 100 papers. He acquired an intense training in Italian and international laboratories. He is the Associate Editor of Journal of Enzyme Inhibition and Medicinal Chemistry, and is in the Editorial Board of the journal Expert Opinion on Therapeutic Patents.

Dr Colinas received his Ph.D. in chemistry from the Universidad Nacional de La Plata (Argentina) en 1997. He then worked as postdoctoral fellow in the Institut für Organische Chemie, Universität Stuttgart (Germany). In 2006 he became Adjunct Professor of organic chemistry in the Universidad Nacional de La Plata. Since 2005 he is member of the Scientific Research Career of CONICET (Argentina). He has published more than 40 scientific publications. His research interests include carbohydrate chemistry, design of enzyme inhibitors and medicinal chemistry.

Dr. Marta Ferraroni obtained his degree and his PhD in Chemistry from the University of Florence, Italy. Currently she is researcher at the Department of Chemistry, University of Florence. The activity of Dr. Ferraroni is primarily focusedon the field of Bioinorganic and Medicinal Chemistry, and its aim is the comprehension of the structure-activity relationships of metalloenzymes involved in relevant processes. Dr. Ferraroni is co-author of 55 scientific articles and of 3 chapter of books edited by international publishing companies.

Prof. Dr. İlhami GÜLÇİN obtained a doctorate (Ph.D.) in Chemistry from the Ataturk University of Erzurum, Turkey. He is the member of Turkish Academy of Sciences (TÜBA). He has experience in the research of enzyme purification, enzyme inhibition, antioxidant activity, and biological activities. He has also published more than 200 scientific publications. His manuscripts have more than 9000 citations.

A. Karioti is Assistant Professor at the Dept. of Pharmaceutical Sciences, Aristotle University of Thessaloniki, Greece, has a Ph.D. in Pharmacognosy of Bioactive Natural Products from the University of Athens, Greece. She served for eight years as Teaching and Research Assistant in Univ. of Florence, Italy (2007-2014). In general the main research lines are Isolation and structural identification of a wide range of natural constituents (both phenols and terpenoids), Pharmacological evalution of extracts and purified constituents and Development of analytical methods for the quality control of herbal medicinal plants and preparations and products thereof. She is author of 77 publications, h-index 19 (google scholar).

Mikhail Krasavin is a Professor of synthetic organic and medicinal chemistry at Saint Petersburg State University (Russia). Prior to assuming this post in 2014, he spent over 10 years in positions of increasing responsibility in pharmaceutical industry (Millennium Pharmaceuticals, Abbott Bioresearch Center, ChemDiv, Inc.) , where he was involved in multiple drug discovery programs in the areas of oncology, metabolic disease, infectious disease and CNS disorders. In 2011-2013 Dr. Krasavin led an independent research group at Eskitis Institute for Drug Discovery (Griffith University) in Braisbane, Australia. Prof. Krasavin has authored more than 100 manuscripts, 8 patents, several book chapters and has consulted various drug discovery and development business entities. In 2016, he was elected a Professor of the Russian Academy of Sciences.

Dr. Mattia Mori obtained his degree in Medicinal Chemistry and his PhD in Structural Biology from the University of Florence, Italy. Currently he is researcher at the Center for Life Nano Science@Sapienza of the Istituto Italiano di Tecnologia (IIT) in Roma, Italy. The research activity of Dr. Mori focuses on medicinal chemistry and drug discovery, with a particular dedication to the use of computer simulations to discover and develop bioactive small molecules, or to study the conformational space of target proteins. Dr. Mori is co-author of more than 45 papers and 1 patent.

Dr. Donald Poirier received his basic training in organic chemistry (PhD at Université Laval, 1980-1985) and subsequently specialized in medicinal chemistry and endocrinology (Post-doctorat at CHUL - Research Center, 1986-1990). Professor at Université Laval since 1991, he is especially interested in the development of inhibitors of steroidogenic enzymes (steroid sulfatase and 17β-HSDs types 1, 2, 3, 7 and 12) and antitumor agents for the treatment of different diseases (breast, prostate and leukemia cancers, endometriosis, osteoporosis and Alzheimer). He is also interested to additional aspects of organic chemistry (synthesis, solid-phase synthesis, new methodologies, NMR analysis, etc.) and medicinal chemistry (SAR and QSAR analysis, molecular modeling, biological assays, etc.). He has published 204 scientific publications and 9 patent applications.

Dr. Shalini Singh is presently working as an Assistant Professor in the Department of Chemistry, Bareilly College, Bareilly (U.P.) India. She holds a Ph.D. from A.P.S. University Rewa, (M.P). She has got awards and rewards of an unending sequence like Recipient of D.S.T. Women Scientist Scheme Award (WOS-A), U.G.C. Research Awardee 2011, Recipient of Indian Chemical Society Award-2012 Dr. Singh has contributed 42 research papers of repute with high impact factor Journal. Singh is Fellow member of Indian Chemical Society Kolkatta, India. Dr Singh is also member of many prestigious Editorials boards of national and international repute like Journal of Enzyme Inhibition and Medicinal Chemistry.

I am a Faculty Professor of Toxicology at Miguel Hernández University (Spain). I started my research career in biochemical Toxicology with the characterization of enzymes involved in the detoxication of organophosphorus insecticides. At the same time I was involved in the characterization of Neuropathy Target Esterase (an esterase target of organophosphorus insecticides) in in vitro cellular models. I performed a postdoctoral stay (2 years) at the Texas A&M University where I was involved the generation and characterization of mutant bacterial phosphotriesterases by site-directed mutagenesis for enhancing and modulating their catalytic efficacy. Nowadays my records include 59 papers in peer-review journals and 8 book chapters.

Sébastien Thibaudeau is professor of organic chemistry at the University of Poitiers. He completed his MD and PhD in Poitiers (France) and a fellowship at chemistry department in Oxford University (UK). He is head of the superacid group in the organic synthesis team of the Institute of Chemistry of Poitiers (IC2MP). His current research is mainly focused on the use of superacid activation in organic and bio-organic chemistry.

Dr. Daniela Vullo obtained her Ph.D. in Chemistry at the University of Florence, Italy. Currently, she has a post-doc position at the same university, Department of Chemistry “Ugo Shiff” under the supervision of Prof. Andrea Scozzafava and Prof. Claudiu T. Supuran. The scientific research is focused on enzyme activity characterization, mainly carbonic anhydrase inhibitors and activators and resulted in the publication of over 280 papers with Hirsch factor h=51 and 9112 citations.